Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

LeadDiscovery

LeadDiscovery was founded in 1998 by life scientists for life scientists. Based on a solid background of experience from within pharmaceutical R&D our aim is to help companies develop their pipelines through the identification of breaking research and the in depth and expert evaluation of selected therapeutic areas. At the same time we provide a showcase for organizations wishing to increase the exposure of their research to the drug development community. We support the drug discovery and development community through two key service: DailyUpdates & PharmaReports


Contact Details:
Unit 4, Quarry Farm
Bodiam
East Sussex
TN32 5RA
United Kingdom
Tel:44 (0)1580 831877
Fax:
Email:leaddisc@leaddiscovery.co.uk
WWW:

www.leaddiscovery.co.uk/




Loading...

Press Releases on LeadDiscovery:

BioPortfolio Logo
Emerging oncology treatments: A focus on targeted therapeutics, 1st June, 2006 Dailyupdates
Emerging oncology treatments: A focus on targeted therapeutics, supergeneric reformulations and supportive care Feb, 2005 Leaddiscovery: The oncology market is the third largest
COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact 1st October, 2004 Dailyupdates
COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact October 20 2004. At the beginning of October, 2004 Merck withdrew the blockbuster Vioxx (Rofecoxib) from the market. This move
SOCS1 silencing dramatically increases the anti-cancer efficacy of 1st June, 2004 Dailyupdates
SOCS1 silencing dramatically increases the anti-cancer efficacy of dendritic cell vaccines 5th January, 2005 E.Sussex , England:  The development of dendritic cell vaccines to
Gabapentin as a first line treatment of spinal cord injury-related 1st May, 2004 Dailyupdates
Gabapentin as a first line treatment of spinal cord injury-related neuropathic pain DailyUpdates 5th May 2004: As the battle lines are drawn up between gabapentin and its
Results from the PACES trials provides further good news for Pfizer's 1st May, 2004 Dailyupdates
Results from the PACES trials provides further good news for Pfizer's Celebrex (celecoxib) DailyUpdates 10th May 2004: Last week European regulators affirmed the safety of

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 188 times since April 2007, the link to the organisation's website has been followed 53 times

Search for more companies in Bodiam

Search for more companies in East Sussex



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for LeadDiscovery

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.